Riik: Ameerika Ühendriigid
keel: inglise
Allikas: NLM (National Library of Medicine)
KETOCONAZOLE (UNII: R9400W927I) (KETOCONAZOLE - UNII:R9400W927I)
Physicians Total Care, Inc.
KETOCONAZOLE
KETOCONAZOLE 20 mg in 1 g
TOPICAL
PRESCRIPTION DRUG
Ketoconazole Cream 2% is indicated for the topical treatment of tinea corporis, tinea cruris and tinea pedis caused by Trichophyton rubrum, T. mentagrophytes and Epidermophyton floccosum; in the treatment of tinea (pityriasis) versicolor caused by Malassezia furfur (Pityrosporum orbiculare) ; in the treatment of cutaneous candidiasis caused by Candida spp. and in the treatment of seborrheic dermatitis. Ketoconazole Cream 2% is contraindicated in persons who have shown hypersensitivity to the active or excipient ingredients of this formulation.
Ketoconazole Cream 2% is supplied as follows: Store below 77°F (25°C). E. FOUGERA & CO. a division of Altana Inc. MELVILLE, NEW YORK 11747 I299 #39 R6/02 Relabeling of "Additional" barcode label by: Physicians Total Care, Inc. Tulsa, OK 74146
Abbreviated New Drug Application
KETOCONAZOLE - KETOCONAZOLE CREAM PHYSICIANS TOTAL CARE, INC. ---------- RX ONLY DESCRIPTION Ketoconazole Cream 2%, for topical administration only, contains the broad-spectrum synthetic antifungal agent, ketoconazole 2%, formulated in an aqueous cream vehicle consisting of propylene glycol, stearyl and cetyl alcohols, sorbitan monostearate, polysorbate 60, isopropyl myristate, sodium sulfite anhydrous, polysorbate 80 and purified water. Ketoconazole is _cis_-1-acetyl-4-[4-[[2-(2,4-dichlorophenyl)-2-(1_H_-imidazol-1-ylmethyl)-1,3-dioxolan- 4-yl]methoxy]phenyl]piperazine and has the following structural formula: CLINICAL PHARMACOLOGY When Ketoconazole Cream 2% was applied dermally to intact or abraded skin of Beagle dogs for 28 consecutive days at a dose of 80 mg, there were no detectable plasma levels using an assay method having a lower detection limit of 2 ng/ml. After a single topical application to the chest, back and arms of normal volunteers, systemic absorption of ketoconazole was not detected at the 5 ng/ml level in blood over a 72-hour period. Two dermal irritancy studies, a human sensitization test, a phototoxicity study and a photoallergy study conducted in 38 male and 62 female volunteers showed no contact sensitization of the delayed hypersensitivity type, no irritation, no phototoxicity and no photoallergenic potential due to Ketoconazole Cream 2%. MICROBIOLOGY: Ketoconazole is a broad spectrum synthetic antifungal agent which inhibits the _in vitro_ growth of the following common dermatophytes and yeasts by altering the permeability of the cell membrane: dermatophytes: _Trichophyton rubrum, T. mentagrophytes, T. tonsurans, Microsporum canis, M._ _audouini, M. gypseum and Epidermophyton floccosum;_ yeasts: _Candida albicans, Malassezia ovale_ _(Pityrosporum ovale)_ and _C. tropicalis;_ and the organism responsible for tinea versicolor, _Malassezia_ _furfur (Pityrosporum orbiculare)_. Only those organisms listed in the INDICATIONS AND USAGE Section have been proven to be clinically affected. Developm Lugege kogu dokumenti